Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 346 clinical trials
Escalated Single Platelet Inhibition for One Month Plus NOAC in Patients With Atrial Fibrillation and ACS Undergoing PCI (EPIDAURUS)

The selection of the optimal antithrombotic therapy in patients with nonvalvular atrial fibrillation (AF) and acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) is

anticoagulation therapy
thrombosis
anticoagulants
noac
vitamin k antagonist
  • 0 views
  • 01 May, 2022
  • 2 locations
Colchicine and Spironolactone in Patients With MI / SYNERGY Stent Registry (CLEAR SYNERGY)

The CLEAR SYNERGY trial will study the long term effects of treatments following PCI to treat myocardial infarction. These treatments address both the culprit artery (PCI with SYNERGY stent) as

diabetes
stemi
troponin
colchicine
  • 23 views
  • 04 Oct, 2022
  • 1 location
Optimized Antiplatelet Therapy on the Prognosis of ACS Patients With Non-predominant Coronary Artery Disease After PCI

percutaneous coronary intervention (PCI).

aspirin
myocardial infarction
infarct
percutaneous coronary intervention
acute coronary syndrome
  • 0 views
  • 24 Jan, 2021
  • 1 location
Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI

More than 25% of patients referred for diagnostic coronary angiography and percutaneous coronary intervention (PCI) due to acute coronary syndrome (ACS) suffer from non-valvular atrial

arterial disease
anticoagulation therapy
myocardial infarction
transient ischemic attack
electrocardiogram
  • 0 views
  • 12 Nov, 2021
  • 1 location
Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion

undergoing elective percutaneous coronary intervention with drug eluting stents for complex coronary lesions.

percutaneous coronary intervention
clopidogrel
antiplatelet therapy
in stent restenosis
prasugrel
  • 0 views
  • 19 Nov, 2021
  • 1 location
"MetCool ACS"- Metformin "Cooling" Effect on Metformin-naive Patients Treated With PCI Because of Acute Coronary Syndrome

coronary revascularization as a result of the first episode of the acute coronary syndrome (ACS).

percutaneous coronary intervention
coronary revascularization
acute coronary syndrome
hba1c
diabetes
  • 0 views
  • 21 Apr, 2022
  • 1 location
The Randomized OPTIMAL-ACT Trial

Despite the widespread adoption of recommended anticoagulation intensity ranges during percutaneous coronary intervention (PCI), there are limited randomized clinical trials testing specific

percutaneous coronary intervention
coronary revascularization
antiplatelet therapy
revascularisation
intravascular ultrasound
  • 0 views
  • 24 Mar, 2022
  • 1 location
Clopidogrel Versus Aspirin MOnotherapy After 1- to 3-month of Dual-antiplatelet thErapy Following Zotarolimus-eluting Onyx Stents Implantation; C-MODE Trial

Previous randomized clinical trials have deomonstrated the efficacy and safety of short-term dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI), however, the single

  • 0 views
  • 22 Oct, 2022
  • 1 location
SMart Angioplasty Research Team: CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 3 (SMART-CHOICE3)

after percutaneous coronary intervention (PCI) with drug-eluting stents (DES) in patients being treated with dual antiplatelet therapy (DAPT) at high risk for recurrent ischemic events.

in stent restenosis
aspirin
myocardial infarction
infarct
percutaneous coronary intervention
  • 0 views
  • 14 Mar, 2022
  • 1 location
Short-term Use of Dapagliflozin to Protect Kidney Function in CKD Patients

coronary intervention, as well as observed the incidence of CIN.

Accepts healthy volunteers
  • 0 views
  • 24 Mar, 2022
  • 1 location